These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 10891472)

  • 1. Thymic atrophy in murine acute graft-versus-host disease is effected by impaired cell cycle progression of host pro-T and pre-T cells.
    Krenger W; Rossi S; Piali L; Holländer GA
    Blood; 2000 Jul; 96(1):347-54. PubMed ID: 10891472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apoptosis of thymocytes during acute graft-versus-host disease is independent of glucocorticoids.
    Krenger W; Rossi S; Holländer GA
    Transplantation; 2000 May; 69(10):2190-3. PubMed ID: 10852622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of both donor cytotoxic T lymphocytes and host NK1.1+ T cells in the thymic atrophy of mice suffering from acute graft-versus-host disease.
    Onoe Y; Harada M; Tamada K; Abe K; Li T; Tada H; Nomoto K
    Immunology; 1998 Oct; 95(2):248-56. PubMed ID: 9824483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Keratinocyte growth factor preserves normal thymopoiesis and thymic microenvironment during experimental graft-versus-host disease.
    Rossi S; Blazar BR; Farrell CL; Danilenko DM; Lacey DL; Weinberg KI; Krenger W; Holländer GA
    Blood; 2002 Jul; 100(2):682-91. PubMed ID: 12091365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4+ T cells generated de novo from donor hemopoietic stem cells mediate the evolution from acute to chronic graft-versus-host disease.
    Zhang Y; Hexner E; Frank D; Emerson SG
    J Immunol; 2007 Sep; 179(5):3305-14. PubMed ID: 17709547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD4-CD8-C.B-17 SCID thymocytes enter the CD4+CD8+ stage in the presence of neonatally grafted T cells.
    Schneider MK; Grönvik KO
    Scand J Immunol; 1998 May; 47(5):466-74. PubMed ID: 9627131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thymic damage, impaired negative selection, and development of chronic graft-versus-host disease caused by donor CD4+ and CD8+ T cells.
    Wu T; Young JS; Johnston H; Ni X; Deng R; Racine J; Wang M; Wang A; Todorov I; Wang J; Zeng D
    J Immunol; 2013 Jul; 191(1):488-99. PubMed ID: 23709681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of normal thymic repertoire selection and persistence of autoreactive T cells in graft vs host disease.
    Holländer GA; Widmer B; Burakoff SJ
    J Immunol; 1994 Feb; 152(4):1609-17. PubMed ID: 7907102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocyte growth factor preserves graft-versus-leukemia effect and T-cell reconstitution after marrow transplantation.
    Imado T; Iwasaki T; Kataoka Y; Kuroiwa T; Hara H; Fujimoto J; Sano H
    Blood; 2004 Sep; 104(5):1542-9. PubMed ID: 15100150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of thymic innate lymphoid cells leads to impaired thymopoiesis in experimental graft-versus-host disease.
    Dudakov JA; Mertelsmann AM; O'Connor MH; Jenq RR; Velardi E; Young LF; Smith OM; Boyd RL; van den Brink MRM; Hanash AM
    Blood; 2017 Aug; 130(7):933-942. PubMed ID: 28607133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of donor T cells for target organ injuries in acute and chronic graft-versus-host disease.
    Kataoka Y; Iwasaki T; Kuroiwa T; Seto Y; Iwata N; Hashimoto N; Ogata A; Hamano T; Kakishita E
    Immunology; 2001 Jul; 103(3):310-8. PubMed ID: 11454060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced immune reconstitution by sex steroid ablation following allogeneic hemopoietic stem cell transplantation.
    Goldberg GL; Alpdogan O; Muriglan SJ; Hammett MV; Milton MK; Eng JM; Hubbard VM; Kochman A; Willis LM; Greenberg AS; Tjoe KH; Sutherland JS; Chidgey A; van den Brink MR; Boyd RL
    J Immunol; 2007 Jun; 178(11):7473-84. PubMed ID: 17513799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mouse embryonic stem cell-derived thymic epithelial cell progenitors enhance T-cell reconstitution after allogeneic bone marrow transplantation.
    Lai L; Cui C; Jin J; Hao Z; Zheng Q; Ying M; Boyd R; Zhao Y
    Blood; 2011 Sep; 118(12):3410-8. PubMed ID: 21791423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing T-cell age reduces effector activity but preserves proliferative capacity in a murine allogeneic major histocompatibility complex-mismatched bone marrow transplant model.
    Friedman JS; Alpdogan O; van den Brink MR; Liu C; Hurwitz D; Boyd A; Kupper TS; Burakoff SJ
    Biol Blood Marrow Transplant; 2004 Jul; 10(7):448-60. PubMed ID: 15205666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of donor mice with an alpha beta T-cell receptor monoclonal antibody induces prolonged T-cell nonresponsiveness and effectively prevents lethal graft-versus-host disease in murine recipients of major histocompatibility complex (MHC)-matched and MHC-mismatched donor marrow grafts.
    Drobyski WR; Majewski D
    Blood; 1996 Jun; 87(12):5355-69. PubMed ID: 8652851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ex vivo fludarabine exposure inhibits graft-versus-host activity of allogeneic T cells while preserving graft-versus-leukemia effects.
    Giver CR; Montes RO; Mittelstaedt S; Li JM; Jaye DL; Lonial S; Boyer MW; Waller EK
    Biol Blood Marrow Transplant; 2003 Oct; 9(10):616-32. PubMed ID: 14569558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs.-host disease.
    Drobyski WR; Majewski D; Hanson G
    Biol Blood Marrow Transplant; 1999; 5(4):222-30. PubMed ID: 10465102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of Fas and Fas ligand in acute and chronic graft-versus-host disease: up-regulation of Fas and Fas ligand requires CD8+ T cell activation and IFN-gamma production.
    Shustov A; Nguyen P; Finkelman F; Elkon KB; Via CS
    J Immunol; 1998 Sep; 161(6):2848-55. PubMed ID: 9743345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FK506 inhibits graft-versus-host disease and bone marrow graft rejection in murine recipients of MHC disparate donor grafts by interfering with mature peripheral T cell expansion post-transplantation.
    Blazar BR; Taylor PA; Fitzsimmons WE; Vallera DA
    J Immunol; 1994 Aug; 153(4):1836-46. PubMed ID: 7519216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ex vivo anti-CD3 antibody-activated donor T cells have a reduced ability to cause lethal murine graft-versus-host disease but retain their ability to facilitate alloengraftment.
    Drobyski WR; Majewski D; Ozker K; Hanson G
    J Immunol; 1998 Sep; 161(5):2610-9. PubMed ID: 9725263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.